Precigen (PGEN) Stock: Buy, Sell, or Hold?
$4.66
-0.06 (-1.27%)
▼
5d:
+10.43%
30d:
-36.64%
90d:
-23.61%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect PGEN Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
LOW Confidence (91%)
Quality Score
65/100
Position
OVERSOLD
30-Day Fair Range
$5.12 – $7.41
Position: OVERSOLD
Forward P/E & Valuation
7.6x
CHEAP
vs 29.2x historical avg
Wall Street Target
$14.00
+200.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.92 / $7.04
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: PGEN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When PGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.06
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$18.66
75.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PGEN is currently trading at $4.66, which is considered oversold relative to its 30-day fair value range of $5.12 to $7.41. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.5) compared to its historical average (29.2). Remarkably, the market is currently pricing in an annual earnings decline of 36.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, PGEN is in a strong uptrend. Immediate support is located at $3.92, while resistance sits at $7.04.
Market Sentiment: PGEN scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+200.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PGEN is in a strong uptrend. Immediate support is located at $3.92, while resistance sits at $7.04.
Market Sentiment: PGEN scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+200.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.12 -
$7.41
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
90.5%
Trading Range & Key Levels
30-Day Trading Range
$5.12 -
$7.41
Current vs Trading Range
OVERSOLD
Support Level
$3.92
Resistance Level
$7.04
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding PGEN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 200.4% below Wall St target ($14.00)
- CAUTION: Bottoming setup, but lagging the sector by 25% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
7.55
Wall Street Target
$14.00
(+200.4%)
Revenue Growth (YoY)
2437.6%
Profit Margin
15.6%
Valuation Discount vs History
-36.3% cheaper
PE vs Historical
7.6 vs 29.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-36.3%
(market-implied from PE analysis)
1-Year Target
$4.19
(-10%)
2-Year Target
$3.77
(-19%)
3-Year Target
$3.40
(-27%)
3-Yr Target (if PE normalizes)
(PE: 8→29)
$13.14
(+182%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 150.6%)
$41.38
(+788%)
Base:
(SPY PE: 7.5, Growth: 150.6%)
$15.73
(+238%)
Bear:
(PE: 6.4, Growth: 150.6%)
$13.37
(+187%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 42.91 | Current EPS (TTM): $0.11
Bull Case
$10.38
(+123%)
Analyst growth 100.0%, PE expands to 47.2
Base Case
$9.44
(+103%)
Market implied 100.0%, PE stable at 42.9
Bear Case
$3.21
(-31%)
Severe decline -20.0%, PE contracts to 36.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.5 to 29.2
Stabilization Target:
$18.03
(+286.9%)
PE Expansion Potential:
+286.9%
Share PGEN Analysis
Share this live PGEN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PGEN)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate bullish sentiment towards $PGEN, with one user highlighting INO as a potential catalyst beyond the current narrative.
Key Retail Themes:
Positive sentiment towards $PGEN
INO as potential catalyst
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:49 AM ET
Data refreshes hourly during market hours. Next update: 5:49 AM
Data refreshes hourly during market hours. Next update: 5:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 32 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 32 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 24 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 48 HOLD |
Advanced PGEN Option Strategies
Professional options setups generated by AI based on today's PGEN price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PGEN Research Pages
